Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Cross-Network Directory Service: Infrastructure to enable collaborations across distributed research networks.

Malenfant JM, Hochstadt J, Nolan B, Barrett K, Corriveau D, Dee D, Harris M, Herzig-Marx C, Nair VP, Wyner Z, Brown JS.

Learn Health Syst. 2019 Feb 14;3(2):e10187. doi: 10.1002/lrh2.10187. eCollection 2019 Apr.

2.

Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction.

Marco EJ, Aitken AB, Nair VP, da Gente G, Gerdes MR, Bologlu L, Thomas S, Sherr EH.

BMC Med Genomics. 2018 May 25;11(1):50. doi: 10.1186/s12920-018-0362-x.

3.

Host-Virus Protein Interaction Network Reveals the Involvement of Multiple Host Processes in the Life Cycle of Hepatitis E Virus.

Subramani C, Nair VP, Anang S, Mandal SD, Pareek M, Kaushik N, Srivastava A, Saha S, Shalimar, Nayak B, Ranjith-Kumar CT, Surjit M.

mSystems. 2018 Jan 23;3(1). pii: e00135-17. doi: 10.1128/mSystems.00135-17. eCollection 2018 Jan-Feb.

4.

Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.

Chrischilles EA, Gagne JJ, Fireman B, Nelson J, Toh S, Shoaibi A, Reichman ME, Wang S, Nguyen M, Zhang R, Izem R, Goulding MR, Southworth MR, Graham DJ, Fuller C, Katcoff H, Woodworth T, Rogers C, Saliga R, Lin ND, McMahill-Walraven CN, Nair VP, Haynes K, Carnahan RM.

Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):263-271. doi: 10.1002/pds.4375. Epub 2018 Jan 10.

PMID:
29318683
5.

Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.

Wang W, Hakim MS, Nair VP, de Ruiter PE, Huang F, Sprengers D, Van Der Laan LJ, Peppelenbosch MP, Surjit M, Pan Q.

Gastroenterology. 2016 Dec;151(6):1251-1253. doi: 10.1053/j.gastro.2016.09.061. Epub 2016 Nov 1. No abstract available.

PMID:
27815000
6.

Prosthetic rehabilitation of surgically treated orbital defects - evisceration, enucleation, and exenteration: A case series.

Babu AS, Manju V, Nair VP, Thomas CT.

J Indian Prosthodont Soc. 2016 Apr-Jun;16(2):216-20. doi: 10.4103/0972-4052.167947.

7.

Identification of critical residues in Hepatitis E virus macro domain involved in its interaction with viral methyltransferase and ORF3 proteins.

Anang S, Subramani C, Nair VP, Kaul S, Kaushik N, Sharma C, Tiwari A, Ranjith-Kumar CT, Surjit M.

Sci Rep. 2016 Apr 26;6:25133. doi: 10.1038/srep25133.

8.

Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus.

Nair VP, Anang S, Subramani C, Madhvi A, Bakshi K, Srivastava A, Shalimar, Nayak B, Ranjith Kumar CT, Surjit M.

PLoS Pathog. 2016 Apr 1;12(4):e1005521. doi: 10.1371/journal.ppat.1005521. eCollection 2016 Apr.

9.

Effect of Impurities on the Josephson Current through Helical Metals: Exploiting a Neutrino Paradigm.

Ghaemi P, Nair VP.

Phys Rev Lett. 2016 Jan 22;116(3):037001. doi: 10.1103/PhysRevLett.116.037001. Epub 2016 Jan 21.

PMID:
26849609
10.

Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.

Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, Bate A.

Drug Saf. 2015 Aug;38(8):767-8. doi: 10.1007/s40264-015-0322-8. No abstract available.

PMID:
26136091
11.

A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.

Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, Bate A.

Drug Saf. 2015 Aug;38(8):749-65. doi: 10.1007/s40264-015-0297-5. Erratum in: Drug Saf. 2015 Aug;38(8):767-8.

PMID:
26055920
12.

Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program.

Cutrona SL, Toh S, Iyer A, Foy S, Daniel GW, Nair VP, Ng D, Butler MG, Boudreau D, Forrow S, Goldberg R, Gore J, McManus D, Racoosin JA, Gurwitz JH.

Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):40-54. doi: 10.1002/pds.3310. Epub 2012 Jun 29.

13.

Design considerations, architecture, and use of the Mini-Sentinel distributed data system.

Curtis LH, Weiner MG, Boudreau DM, Cooper WO, Daniel GW, Nair VP, Raebel MA, Beaulieu NU, Rosofsky R, Woodworth TS, Brown JS.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:23-31. doi: 10.1002/pds.2336.

PMID:
22262590
14.

The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program.

Forrow S, Campion DM, Herrinton LJ, Nair VP, Robb MA, Wilson M, Platt R.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:12-7. doi: 10.1002/pds.2242.

PMID:
22262588
15.

Penetration of medication safety technology in community hospitals.

Schumock GT, Nair VP, Finley JM, Lewis RK.

J Med Syst. 2003 Dec;27(6):531-41.

PMID:
14626478
16.

Level quantization for the noncommutative Chern-Simons theory.

Nair VP, Polychronakos AP.

Phys Rev Lett. 2001 Jul 16;87(3):030403. Epub 2001 Jul 2.

PMID:
11461544
17.

Comment on "Anyon in an external electromagnetic field: Hamiltonian and Lagrangian formulations"

Jackiw R, Nair VP.

Phys Rev Lett. 1994 Oct 3;73(14):2007-2008. No abstract available.

PMID:
10056946
18.

Hamiltonian analysis of the effective action for hard thermal loops in QCD.

Nair VP.

Phys Rev D Part Fields. 1994 Sep 15;50(6):4201-4208. No abstract available.

PMID:
10018060
19.

High-temperature response functions and the non-Abelian Kubo formula.

Jackiw R, Nair VP.

Phys Rev D Part Fields. 1993 Nov 15;48(10):4991-4998. No abstract available.

PMID:
10016153
20.

Hard thermal loops, gauged WZNW action, and the energy of hot quark-gluon plasma.

Nair VP.

Phys Rev D Part Fields. 1993 Oct 15;48(8):R3432-R3435. No abstract available.

PMID:
10016676
21.

Chern-Simons theory and the quark-gluon plasma.

Efraty R, Nair VP.

Phys Rev D Part Fields. 1993 Jun 15;47(12):5601-5614. No abstract available.

PMID:
10015587
22.

Action for the hot gluon plasma based on the Chern-Simons theory.

Efraty R, Nair VP.

Phys Rev Lett. 1992 May 11;68(19):2891-2894. No abstract available.

PMID:
10045521
23.

Black holes in magnetic monopoles.

Lee K, Nair VP, Weinberg EJ.

Phys Rev D Part Fields. 1992 Apr 15;45(8):2751-2761. No abstract available.

PMID:
10014665
24.

A classical instability of Reissner-Nordström solutions and the fate of magnetically charged black holes.

Lee K, Nair VP, Weinberg EJ.

Phys Rev Lett. 1992 Feb 24;68(8):1100-1103. No abstract available.

PMID:
10046080
25.

Relativistic wave equation for anyons.

Jackiw R, Nair VP.

Phys Rev D Part Fields. 1991 Mar 15;43(6):1933-1942. No abstract available.

PMID:
10013570
26.

QCD vacuum as a chromomagnetic superconductor: Microscopic physics.

Nair VP, Rosenzweig C.

Phys Rev D Part Fields. 1985 Jan 15;31(2):401-410. No abstract available.

PMID:
9955697
27.

The merciless sun.

Nair VP.

Singapore Med J. 1978 Dec;19(4):234-7. No abstract available.

PMID:
751210

Supplemental Content

Support Center